Product approvals

This undated image provided by AbbVie in July 2018 shows packaging for the company's drug Orilissa (elagolix). On Tuesday, July 24, 2018, the company said that The Food and Drug Administration approved its the drug for pain during menstruation and at other times. (AbbVie via AP)
July 24, 2018 - 12:07 pm
TRENTON, N.J. (AP) — A new treatment for pain caused by endometriosis was approved Tuesday by U.S. regulators. The common condition involves abnormal tissue growth from the uterus that can cause severe pain and infertility. Drugmaker Abbvie said the Food and Drug Administration approved the drug,...
Read More
This 1975 microscope image made available by the Centers for Disease Control and Prevention shows a cluster of smallpox viruses. On Friday, July 13, 2018, U.S. regulators announced the approval of the first treatment for smallpox _ a deadly disease that was wiped out four decades ago _ in case the virus is used in a terror attack. (Fred Murphy/CDC via AP)
July 13, 2018 - 5:37 pm
U.S. regulators have approved the first treatment for smallpox — a deadly disease that was wiped out four decades ago — in case the virus is used in a terror attack. Smallpox, which is highly contagious, was eradicated worldwide by 1980 after a huge vaccination campaign. But people born since then...
Read More
In this April 23, 2018, photo, Meagan Patrick kisses her daughter, Addelyn Patrick, 5, in the playroom at Realm of Caring in Colorado Springs, Colo. Addelyn was born with a brain malformation and suffers from multiple forms of seizures. The U.S. Food and Drug Administration is expected to decide soon whether to give its first approval to a prescription drug made from the marijuana plant. But parents, including Meagan, who have used other products containing chemicals from the plant to treat their children’s severe forms of epilepsy are feeling more cautious than celebratory. (AP Photo/Thomas Peipert)
June 19, 2018 - 2:11 am
COLORADO SPRINGS, Colorado (AP) — The U.S. Food and Drug Administration is expected to decide soon whether to give its first approval to a prescription drug made from the marijuana plant. But parents who have used other products containing chemicals from the plant to treat their children's severe...
Read More
June 04, 2018 - 3:00 am
BERLIN (AP) — German pharmaceutical company Bayer AG said Monday that it plans to complete its purchase of U.S. seed and weed-killer maker Monsanto Co. this week after receiving all the required approvals from regulators. Bayer said in a statement that it plans to complete the acquisition on...
Read More
President Donald Trump hugs Duchenne Muscular Dystrophy patient Jordan McLinn after signing the "Right to Try" act in the South Court Auditorium on the White House campus, Wednesday, May 30, 2018, in Washington. (AP Photo/Evan Vucci)
May 30, 2018 - 2:03 pm
WASHINGTON (AP) — President Donald Trump signed legislation Wednesday aimed at helping people with deadly diseases try experimental treatments, calling it a "fundamental freedom" that will offer hope and save lives. Joined by families dealing with amyotrophic lateral sclerosis, also called Lou...
Read More
This May 10, 2018, image provided by Amgen Inc. shows an artist's rendering of the packaging for the drug Aimovig, the first in a new class of long-acting drugs designed to prevent chronic migraines. On Thursday, May 17, 2018, the Food and Drug Administration approved the medication, clearing the monthly shot for sale. (Amgen Inc. via AP)
May 17, 2018 - 7:24 pm
TRENTON, N.J. (AP) — U.S. regulators Thursday approved the first drug designed to prevent chronic migraines. The Food and Drug Administration's action clears the monthly shot Aimovig (AIM'-oh-vig) for sale. It's the first in a new class of long-acting drugs for preventing migraines. Three other...
Read More
May 17, 2018 - 8:38 am
TOKYO (AP) — Japanese electronics company Toshiba Corp. says the sale of its computer memory chip business to a consortium led by Bain Capital Private Equity has cleared all anti-trust regulatory approval, including a final one it was awaiting from China. Toshiba said Thursday that means the deal,...
Read More
FILE - In this Friday, July 8, 2016 file photo, a prescription is filled at a pharmacy in Sacramento, Calif. On Friday, May 11 2018, Trump is scheduled to give his first speech on how his administration will seek to lower drug prices. (AP Photo/Rich Pedroncelli, File)
May 10, 2018 - 8:07 pm
WASHINGTON (AP) — Before taking office, President Donald Trump railed against the pharmaceutical industry and accused it of "getting away with murder." The populist rhetoric appears to be giving way to a more nuanced strategy focused on making the pharmaceutical market more open and competitive,...
Read More
FILE - This May 23, 2017 file photo shows GW Pharmaceuticals’ Epidiolex, a medicine made from the marijuana plant but without THC. On Thursday, April 19, 2018, a panel of Food and Drug Administration health advisers recommended approval of the drug, moving the closely watched medication closer to the U.S. market. (AP Photo/Kathy Young, File)
April 19, 2018 - 1:05 pm
WASHINGTON (AP) — A medicine made from the marijuana plant moved one step closer to U.S. approval Thursday after federal health advisers endorsed it for the treatment of severe seizures in children with epilepsy. If the Food and Drug Administration follows the group's recommendation, GW...
Read More
April 17, 2018 - 11:46 am
WASHINGTON (AP) — U.S. health officials on Tuesday proposed steps to improve the government's system for overseeing medical devices, which has been criticized for years for failing to catch problems with risky implants and medical instruments. The plan from the Food and Drug Administration includes...
Read More

Pages